Ventrix provides regenerative medicine solutions for the heart. The company is working to commercialize innovative non-cellular biomaterial products that halt left ventricular remodeling and reduce heart failure after myocardial infarction. Ventrix is a privately-held company located in San Diego, CA, near key collaborators and founders at the University of California, San Diego. Ventrix was founded based on the possibilities novel regenerative medicine approaches offer the field of cardiology. Ventrix minimally-invasive technologies deliver a regenerative medicine product directly to the myocardium, offering unparalleled simplicity, ease of delivery and effectiveness in preserving cardiac function after a heart attack
